Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (1004)	9/9/2003 8:45:01 PM
From: SemiBull	Read Replies (1) \| Respond to of 1139

ICOS Files Shelf Registration Statement Tuesday September 9, 4:24 pm ET BOTHELL, Wash.--(BUSINESS WIRE)--Sept. 9, 2003--ICOS Corporation (Nasdaq:ICOS - News) today announced that it has filed a shelf registration statement on Form S-3, with the U.S. Securities and Exchange Commission, to register for resale its 2.0% Convertible Subordinated Notes due 2023 issued in June and July 2003 in a private placement, and its common shares issuable upon conversion of those Notes. The registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective except in reliance on an exemption from the registration requirements of the Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Copies of the registration statement, including the prospectus subject to completion contained therein, are available on the SEC's web site at www.sec.gov and may also be obtained on the Company's Web site at www.icos.com under the Investors-Financial section. Contact: ICOS Corporation Lacy Fitzpatrick, 425-415-2207 Source: ICOS Corporation